Abhishek Shankar, Affiliate Professor of the Division of Radiation Oncology at All India Institute of Medical Sciences, shared a submit on LinkedIn by Devex, including:
“This is a crucial public well being consideration.
Those that are eligible for lung most cancers screening are inspired to go for it.
Kindly electronic mail me at doc.abhishankar@gmail.com to get it carried out at AIIMS, Delhi or any a part of the nation beneath the Indian lung screening trial, funded by the Bristol Myers Squibb Basis.”
Quoting Devex:
“Lung most cancers screening pointers have largely been formed by smoking historical past. However in India, the place an estimated 40% to 50% of individuals dwelling with lung most cancers are never-smokers, does that strategy seize everybody who could also be in danger?
In a brand new Devex-sponsored opinion piece, Catharine Grimes, president of the Bristol Myers Squibb Basis (BMS Basis), and Dr. Abhishek Shankar, radiation oncologist on the All India Institute of Medical Sciences (AIIMS), discover how two new trials in India are constructing regionally grounded proof round lung most cancers threat and screening.
The AIRCARE initiative is inspecting the position of air air pollution, together with PM2.5 publicity, alongside behavioral, medical, and genetic threat components. In parallel, the Indian Lung Screening Trial is evaluating how low-dose CT screening may work inside India’s well being system.
Learn the full opinion piece.”
Different articles that includes Abhishek Shankar on OncoDaily.
